Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual Meeting of Shareholders, held in Osaka today.

Protagonist Therapeutics Inc. (NASDAQ:PTGX) is one of the best mid cap growth stocks to invest in now. Just as June began, ...

View the latest Takeda Pharmaceutical Co. Ltd. ADR (TAK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

View today's Takeda Pharmaceutical Co., Ltd. stock price and latest 4502 news and analysis. Create real-time notifications to follow any changes in the live stock price.

A high-level overview of Takeda Pharmaceutical Company Limited (TAK) stock. View (TAK) real-time stock price, chart, news, analysis, analyst reviews and more.

Get the annual and quarterly balance sheet of Takeda Pharmaceutical Company Limited (TAK) including details of assets, liabilities and shareholders' equity.

ADMA Biologics ADMA and Takeda TAK are leading players in the plasma derived immunoglobulin sector. ADMA markets ...

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TOKYO:4502/NYSE:TAK) has announced new assignments of directors, determined at the Board of Directors meeting, following the 149th Annual ...

Invagen Pharmaceuticals Inc. will add 70 medical manufacturing jobs with a state tax incentive program worth almost $1.8 ...

According to Takeda Pharmaceuticals, the average time taken to diagnose a rare disease without technology is 7.6 years, and that comes after countless tests and physician visits.